-
Trends in EMA-Approved New Medicines 2015-2024: New Mechanisms of Action and Regulatory Shifts
Sep 9, 2025, 16:22 PM -
A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research
Sep 9, 2025, 16:22 PM -
Exploring Artificial Intelligence's (AI's) Role in Literature Screening: A Comparative Analysis Paving the Way for More Efficient Evidence Synthesis
Sep 9, 2025, 16:22 PM -
Budget Impact of Introducing Accuchek® Smartguide Real-Time Continuous Glucose Monitoring (RtCGM) Solution for Diabetes Management in Portugal
Sep 9, 2025, 16:22 PM -
German Early Benefit Assessments and the Impact of Medical Societies: An Analysis
Sep 9, 2025, 16:22 PM -
Improving Patient Flow and Multidisciplinary Coordination in Urothelial Carcinoma: Insights From Bulgarian Oncologists
Sep 9, 2025, 16:22 PM -
Extent and Causes of the Collapse in the Registration of Innovative Medications in Lebanon: A Mixed-Methods Analysis
Sep 9, 2025, 16:22 PM -
Are Glucagon-Like Peptide-1 Receptor Agonists Prescribed for Weight Loss Slipping Through the Net of Japan’s Strict Guidelines? An Analysis of Health Insurance Claims Data
Sep 9, 2025, 16:22 PM -
Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK
Sep 9, 2025, 16:22 PM -
Reducing Healthcare Costs and Addressing Health Equity Through Improved Treatment Adherence and Reduced Exacerbation Risk in Chronic Obstructive Pulmonary Disease: Real-World Evidence From a Danish Nationwide Cohort Study
Sep 9, 2025, 16:22 PM -
Improving Indirect Treatment Comparisons via an Alternative MAIC Patient Weighting Method
Sep 9, 2025, 16:22 PM -
Examining Knowledge Regarding Needlestick Injuries Among Students in Higher Healthcare Education
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of T-DM1 vs. Trastuzumab for Adjuvant Treatment in HER2 Early Breast Cancer (eBC) With Residual Disease in Colombia
Sep 9, 2025, 16:22 PM -
Designing Digital Healthcare Professional Surveys: A Methodological Overview
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison of Obecabtagene Autoleucel vs. Blinatumomab Inotuzumab Ozogamicin and Ponatinib in Relapsed or Refractory Adult B-cell Acute Lymphoblastic Leukemia
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of High-Dose vs. Adjuvanted Trivalent Influenza Vaccines in Older Adults in Korea
Sep 9, 2025, 16:22 PM -
The Impact on Life Expectancy of Delaying or Avoiding Type 1 Diabetes Using the Metabo-Reno-Cardiovascular Disease Model
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 1 Diabetes in Sweden: A National Real-World Evidence Perspective
Sep 9, 2025, 16:22 PM -
Optimizing Therapeutic Strategies for Multiple Sclerosis in Italy: A Budget Impact Analysis
Sep 9, 2025, 16:22 PM -
Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nirogacestat in Patients With Desmoid Tumors
Sep 9, 2025, 16:22 PM
